The Spanish Society of Medical Oncology (SEOM) and the Spanish Association of Biosimilar Medicines (BioSim) have prepared a video on biosimilars for patients titled “Biosimilars in oncology: What are they and what do they provide for patients?”
It explains that these drugs are similar to the originals, with controlled variability that does not compromise either efficacy or safety. Likewise, it is specified that they have studies that demonstrate this comparability with very strict criteria regulated by health authorities as well as strict quality and safety control. And, in addition, they contribute to the sustainability of the health system.
It explains that these drugs are similar to the originals, with controlled variability that does not compromise either efficacy or safety. Likewise, it is specified that they have studies that demonstrate this comparability with very strict criteria regulated by health authorities as well as strict quality and safety control. And, in addition, they contribute to the sustainability of the health system.